Research Involving:
Drug
This is where the drug category posts show up.
CureAccelerator Live!, Current Research, Dr. Gordon, Drug, Minority/Underserved, Oncology, Pediatric, Rare, The University of Texas MD Anderson Cancer Center
Enhancing Treatment Response in Recurrent/Metastatic Osteosarcoma with Hydroxychloroquine Principal Investigator: Dr. Nancy Gordon Disease: Osteosarcoma Research Description: Osteosarcoma (OS) is an orphan disease affecting approximately 400 children and adolescents...
Adult, Chicago, CureAccelerator Live!, Current Research, Drug, Loyola University Medical Center, Oncology, Rare
Repurposing the Blood Pressure Drug Minoxidil for the Treatment of Recurrent Chemo-Resistant Ovarian Cancer Principal Investigator: Dr. Margaret Liotta Disease: Ovarian cancer Research Description: Epithelial ovarian cancer is the most lethal among the gynecological...
Adult, Current Research, Dr. Lewine, Drug, Military/Veteran, Neuro, University of New Mexico
Repurposing N-Acetylcysteine to Reduce Oxidative Stress, an Important Factor in Traumatic Brain Injury Principal Investigator: Dr. Jeffrey David Lewine Disease: Traumatic Brain Injury Research Description: Mild traumatic brain injury (mTBI) afflicts millions of...
CureAccelerator Live!, Current Research, Dr. Teng, Drug, Pediatric, Rare, Stanford University
Treating Vascular Malformations Using the Cancer Drug Trametinib Principal Investigator: Dr. Joyce Teng Disease: Extracranial arteriovenous malformations Research Description: Extracranial arteriovenous malformation (AVM) is a network of abnormal blood vessels more...
CureAccelerator Live!, Current Research, Dr. Rower, Drug, Hearing Loss, Infectious Disease, Inner Ear, Pediatric, Rare, University of Utah
Repurposing the Antiviral Drug Valganciclovir to Treat Cytomegalovirus-Induced Hearing Loss Principal Investigator: Dr. Joseph Rower Disease: Hearing loss Research Description: Almost 400 children die each year from congenital cytomegalovirus (cCMV) infections, and...
Combo, Current Research, Drug, Oncology, Pre-clinical, Prof. Allen, Rare, University of Cambridge
Testing two generic drugs to improve outcomes in osteosarcoma, a rare bone cancer Principal Investigator: Prof. Matthew Allen Disease: Osteosarcoma Research Description: Although osteosarcoma (OSA) is a rare type of cancer, it is the most common bone cancer in...
